Jump to content
  • Sign Up
0
Scott Adams

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody ... - PR-USA.net (press release)

Rate this topic

Recommended Posts

Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody ...

PR-USA.net (press release)

"We are delighted to have been awarded this grant from the NIH in recognition of the potential of our novel approach to the treatment of celiac disease," said Barbara S. Fox, Ph.D., Avaxia's founder and CEO. "This NIH support provides the funding we ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×